The long-term cardiovascular safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in high-risk cardiovascular populations: a systematic review and meta-analysis.
Saved in:
| Title: | The long-term cardiovascular safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in high-risk cardiovascular populations: a systematic review and meta-analysis. |
|---|---|
| Authors: | Peter K; School of Medicine, Anglia Ruskin University, Bishop Hall Road, Chelmsford, CM1 1SQ, UK., Roka O; School of Medicine, Anglia Ruskin University, Bishop Hall Road, Chelmsford, CM1 1SQ, UK., Sepp E; School of Medicine, Anglia Ruskin University, Bishop Hall Road, Chelmsford, CM1 1SQ, UK., Warburton M; School of Medicine, Anglia Ruskin University, Bishop Hall Road, Chelmsford, CM1 1SQ, UK., Zhang J; School of Medicine, Anglia Ruskin University, Bishop Hall Road, Chelmsford, CM1 1SQ, UK., Cork SC; School of Medicine, Anglia Ruskin University, Bishop Hall Road, Chelmsford, CM1 1SQ, UK. simon.cork@aru.ac.uk. |
| Source: | Cardiovascular diabetology. Endocrinology reports [Cardiovasc Diabetol Endocrinol Rep] 2026 May 01; Vol. 12 (1). Date of Electronic Publication: 2026 May 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 9918994893106676 Publication Model: Electronic Cited Medium: Internet ISSN: 3059-4057 (Electronic) Linking ISSN: 30594057 NLM ISO Abbreviation: Cardiovasc Diabetol Endocrinol Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
